Compare Abeona Therapeutics Inc (ABEO) vs Invesco DB Agriculture Fund (DBA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Invesco DB Agriculture Fund — how do they compare? Abeona Therapeutics Inc trades at $6.72 (market cap $373.32M), while Invesco DB Agriculture Fund trades at $27.59. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Invesco DB Agriculture Fund nearer its low. Which is the better fit depends on your goals.
| ABEO | DBA | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | — |
52-Week High | $7.23 | $28.73 |
52-Week Low | $4.17 | $25.44 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
DBA (Invesco DB Agriculture Fund) trades at $27.54, up 2.99% with strong bullish technical signals from moving averages. The fund tracks agricultural commodities including corn, soybeans, and livestock futures. Recent news highlights supply disruptions in Brazil's coffee harvest and China's $17 billion crop purchase commitment through 2028, creating favorable conditions for agricultural ETFs.
The agricultural commodity rally presents upside potential, though overbought RSI readings suggest near-term consolidation. Key risks include weather volatility affecting crop yields and geopolitical impacts on global trade flows. The fund's diversified exposure offers hedging benefits against inflation but remains sensitive to commodity price swings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Invesco DB Agriculture Fund
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →
